Suvretta Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-255,000
| Closed | -$1.42M | – | 101 |
|
|
2025
Q1 | $1.42M | Buy |
+255,000
| New | +$1.42M | 0.05% | 81 |
|
|
2023
Q3 | – | Sell |
-492,924
| Closed | -$3.83M | – | 100 |
|
|
2023
Q2 | $3.83M | Sell |
492,924
-1,409,719
| -74% | -$10.9M | 0.2% | 64 |
|
|
2023
Q1 | $10.8M | Hold |
1,902,643
| – | – | 0.46% | 47 |
|
|
2022
Q4 | $11.2M | Hold |
1,902,643
| – | – | 0.47% | 50 |
|
|
2022
Q3 | $6.09M | Buy |
1,902,643
+640,179
| +51% | +$2.05M | 0.25% | 53 |
|
|
2022
Q2 | $5.66M | Buy |
1,262,464
+821,768
| +186% | +$3.68M | 0.22% | 62 |
|
|
2022
Q1 | $2.35M | Hold |
440,696
| – | – | 0.07% | 72 |
|
|
2021
Q4 | $6.48M | Buy |
440,696
+291,596
| +196% | +$4.29M | 0.13% | 70 |
|
|
2021
Q3 | $3.12M | Buy |
+149,100
| New | +$3.12M | 0.05% | 84 |
|
|
2021
Q1 | – | Sell |
-252,910
| Closed | -$8.56M | – | 124 |
|
|
2020
Q4 | $8.56M | Buy |
+252,910
| New | +$8.56M | 0.12% | 64 |
|
|
2020
Q3 | – | Sell |
-76,432
| Closed | -$2.58M | – | 111 |
|
|
2020
Q2 | $2.58M | Buy |
+76,432
| New | +$2.58M | 0.06% | 66 |
|